// App-Quantinova.ai

566 : Improved use of clinical variables for prognosis of distant recurrence in patients with ER+ breast cancer treated with 5 years endocrine therapy.

Researchers

Presenter

  • Ivana Sestak

Principal Investigators

  • Belinda Yeo

  • Andrew Dodson

  • Mitch Dowsett

  • Jack M. Cuzick

Medical Centers

  • Centre for Cancer Prevention, Queen Mary University of London, London, United Kingdom

  • Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom

  • Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom

  • Wolfson Institute of Preventive Medicine, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Human epidermal growth factor receptor 2

  • Transthyretin

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved